l-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate
- 30 April 1998
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (4), 931-936
- https://doi.org/10.1016/s0022-5223(98)70376-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Nitric oxide signaling in ischemic heartCardiovascular Research, 1995
- Supplemental l-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injuryThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Inositol trisphosphate and calcium signallingNature, 1993
- Endothelial and Myocardial Cell Protection by a Cysteine-Containing Nitric Oxide Donor After Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1993
- Biochemistry of Nitric Oxide and Its Redox-Activated FormsScience, 1992
- Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.Journal of Clinical Investigation, 1992
- Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.Circulation Research, 1989
- Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscleEuropean Journal of Pharmacology, 1988
- Stimulation of phosphatidylinositol metabolism in the isolated, perfused rat heart.Circulation Research, 1987
- Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human plateletsBiochemical and Biophysical Research Communications, 1986